Abstract
The interaction of neuroactive steroids with the ς1-receptor was investigated in Swiss mice submitted to the forced swimming test. The ς1-agonists igmesine and (+)-SKF-10,047 and the steroid dehydroepiandrosterone sulfate (DHEAS) showed some antidepressant-like activity by shortening the immobility time, these effects being blocked by the ς1-antagonist BD1047 or progesterone. The ς1-agonist PRE-084 or pregnenolone sulfate failed to affect the immobility time. In adrenalectomized/castrated (AdX/CX) mice, the effects of igmesine and DHEAS were significantly potentiated, and PRE-084 or pregnenolone sulfate induced significant decreases of immobility time. The augmented effects in AdX/CX were fully blocked by BD1047. The effects of the classical antidepressants, desipramine or fluoxetine, were unchanged in AdX/CX mice. The effect of stress on the ς1-receptor binding and neurosteroid levels was then examined in different brain structures, in terms of in vivo (+)-[3H]SKF-10,047 binding to ς1-sites and neurosteroids levels. In the hippocampus, but not in the cortex or cerebellum, inhibition of in vivo (+)-[3H]SKF-10,047 binding was measured in parallel to the extent of progesterone levels according to the endocrine conditions. These data confirmed the antidepressant ability of ς1-receptor agonists and revealed that the endogenous steroidal levels tonically interfere with the efficacy of the ς1-system. It was observed that local modifications in progesterone levels are directly related to the changes of in vivo ς1-binding. Such observations may be of major importance in view of the therapeutic use of selective ς1-agonists in depression.
Footnotes
-
This work was supported by Pfizer-Fresnes (France).
- Abbreviations:
- DHEA
- dehydroepiandrosterone
- DHEAS
- dehydroepiandrosterone sulfate
- GABAA
- γ-aminobutyric acid type A receptor
- AdX/CX
- adrenalectomized/castrated mice
- PRE-084
- 2-(4-morpholinoethyl)-1-phenylcyclohexane-1-carboxylate hydrochloride
- BD1047
- N-[2-(3,4-dichlorophenyl)ethyl]-N-methyl-2-(dimethylamino)ethylamine
- Received December 14, 2000.
- Accepted May 17, 2001.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|